Global Orexin Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orexin Receptor Antagonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.
Orexin Receptor Antagonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orexin Receptor Antagonists market is projected to reach US$ 6887.8 million in 2029, increasing from US$ 4521 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Insomnia and Anxious are the major drivers for the industry.
Increased prevalence of various sleep disorders such as insomnia and parasomnias, along with rising incidence of depression and other distressing disorders are major factors driving insomnia. Expanding the Global Insomnia Market. Sleep disturbance is a common symptom of depression. For example, according to the World Health Organization (WHO), approximately 280 million people worldwide suffer from depression. Hence, the surge in the prevalence of psychotic depression across the world has led to the expansion of the insomnia market. In addition, long-term use of a drug to treat a chronic condition may cause certain adverse effects, some of which are thought to impair a patient's ability to get a good night's sleep. This means that the expansion of the market is driven by the increasing prevalence of chronic diseases such as cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orexin Receptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Eisai Co., Ltd
Sun Pharmaceutical Industries Ltd
Novartis AG
Endo Pharmaceuticals plc
Mylan NV
Cereve Inc.
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceuticals Inc
Merck & Co.
Sanofi
Currax Pharmaceuticals LLC
Pfizer Inc.
Segment by Type
Oral
Parenteral
Insomnia
Anxious
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orexin Receptor Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orexin Receptor Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orexin Receptor Antagonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orexin Receptor Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orexin Receptor Antagonists introduction, etc. Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orexin Receptor Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Orexin Receptor Antagonists report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orexin Receptor Antagonists market is projected to reach US$ 6887.8 million in 2029, increasing from US$ 4521 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Insomnia and Anxious are the major drivers for the industry.
Increased prevalence of various sleep disorders such as insomnia and parasomnias, along with rising incidence of depression and other distressing disorders are major factors driving insomnia. Expanding the Global Insomnia Market. Sleep disturbance is a common symptom of depression. For example, according to the World Health Organization (WHO), approximately 280 million people worldwide suffer from depression. Hence, the surge in the prevalence of psychotic depression across the world has led to the expansion of the insomnia market. In addition, long-term use of a drug to treat a chronic condition may cause certain adverse effects, some of which are thought to impair a patient's ability to get a good night's sleep. This means that the expansion of the market is driven by the increasing prevalence of chronic diseases such as cancer.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orexin Receptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Eisai Co., Ltd
Sun Pharmaceutical Industries Ltd
Novartis AG
Endo Pharmaceuticals plc
Mylan NV
Cereve Inc.
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceuticals Inc
Merck & Co.
Sanofi
Currax Pharmaceuticals LLC
Pfizer Inc.
Segment by Type
Oral
Parenteral
Segment by Application
Insomnia
Anxious
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orexin Receptor Antagonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orexin Receptor Antagonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orexin Receptor Antagonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orexin Receptor Antagonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orexin Receptor Antagonists introduction, etc. Orexin Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Orexin Receptor Antagonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices